CT Antigen TCR-redirected T Cells for Ovarian Cancer.
Clinical trial NCT01567891 · COMPLETED
Trial details
- NCT number
- NCT01567891
- Sponsor
- Adaptimmune
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-09
- Primary completion
- 2017-06-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.